source
- Sun Pharma’s $12 billion Organon deal signals global push but India still faces R&D hurdlesSun Pharma is close to completing a nearly $12 billion purchase of Organon, which would lift the Indian group into the world’s top‑25 pharmaceutical companies and expand its footprint to about 150…
- FDA places clinical hold on Aardvark’s Prader-Willi drug amid heart safety concernsThe Food and Drug Administration has issued a clinical hold on Aardvark Therapeutics' experimental treatment ARD-101 for Prader-Willi Syndrome after safety signals were identified. The hold follow…